Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer ...

The global pharma market is over $1.6 trillion. That's with a 90 percent failure rate. We intend to invert that number. How many patients will benefit if 90 percent of drugs in development proved ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence (AI). Traditionally, drug development has been a lengthy, costly ...

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical ...

Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to ...

Kenox Pharmaceuticals expands GMP capabilities ... These new capabilities will streamline and de-risk the early stages of drug development for Kenox partners/clients thereby providing a one ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

PRINCETON, N.J., Jan. 28, 2025 /PRNewswire/ -- Kenox Pharmaceuticals Inc (Kenox ... clinical studies to its comprehensive suite of drug development services. This strategic expansion underscores ...